News

The bacteria behind gum disease may not stop at your teeth. New preliminary research suggests they can reach the heart’s aortic valve, driving the inflammation and calcium buildup behind one of the most common — and most serious — heart ...

A large new study has found that some hormonal contraceptives are linked to a higher risk of meningioma — the most common type of brain tumor in adults, and one that is usually benign. But the headline needs context: the ...

Crossword puzzles and brain games get a lot of credit for keeping the mind sharp — but a new study points to something far simpler: how fast you walk. Researchers found that adults in their 80s who kept up an ...

A new kind of weight-loss medication has arrived — and it comes as a once-daily pill rather than an injection. In April 2026, the U.S. Food and Drug Administration approved Foundayo (orforglipron), the first GLP-1 pill that can be taken ...

A healthy lifestyle is one of the most reliable ways to protect the brain as we age. Regular physical activity, a nutritious diet, quality sleep, staying socially connected, avoiding tobacco, and limiting alcohol have all been linked to a lower ...

As the use of weight-loss medications continues to grow, researchers are increasingly examining their effects beyond weight reduction. One area receiving greater attention is bone health, particularly among people with type 2 diabetes, who may face an increased risk of ...

Managing high blood pressure is one of the most important ways to slow kidney damage in people with type 2 diabetes. However, new research is raising questions about whether one commonly used class of blood pressure medications may not be ...

Exercise has always been a cornerstone of blood pressure management, but a new analysis suggests the type of workout you choose may matter more than previously thought. A pooled analysis published in the British Journal of Sports Medicine found that ...

Breast cancer remains one of the most commonly diagnosed cancers worldwide. In 2022 alone, an estimated 2.3 million women were newly diagnosed, and approximately 670,000 deaths were linked to the disease globally. While treatment options for breast cancer have expanded ...

The U.S. Food and Drug Administration announced on April 30, 2026, that it is considering removing several popular GLP-1 medications from the agency’s 503B bulks list — a decision that could significantly reduce the supply of compounded versions of these ...